Takeda: Hypertension trials

The registry lists 46 Hypertension studies with Takeda as lead sponsor. 0 are open to participants now and 38 have results posted.

Phase 1 3Phase 2 6Phase 3 24Phase 4 4No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Azilsartan in Children From 6 to Less Than 16 Years Old With High Blood PressureCompletedNCT05107960Results posted
• A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood PressureCompletedNCT04668157Phase 3Results posted
• Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle GlaucomaCompletedNCT03131167Phase 1Results posted
• A Phase 3 Long-term Study of TAK-536 in Pediatric Patients 6 to Less Than 16 Years With HypertensionCompletedNCT02791438Phase 3Results posted
• International Multicenter, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Participants With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of KazakhstanCompletedNCT02756819Results posted
• Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in AsiaCompletedNCT02517866Phase 4Results posted
• Azilsartan Medoxomil (TAK-491) Compared to Valsartan in Chinese Participants With HypertensionCompletedNCT02480764Phase 3Results posted
• A Phase 3 Pharmacokinetic Study of TAK-536 (Azilsartan) in Pediatric Patients 6 to Less Than 16 Years With HypertensionCompletedNCT02451150Phase 3Results posted
• A Phase 1 Food Effect Study of TAK-536TCH Final Formulation TabletCompletedNCT02348658Phase 1Results posted
• A Phase III Long-term Study of TAK-536TCH in Participants With Essential HypertensionCompletedNCT02277691Phase 3Results posted
• Candesartan Cilexetil Special Drug Use Surveillance 「Challenge - Quality Control」CompletedNCT02211638Results posted
• Azilsartan Medoxomil (TAK-491) Compared to Placebo in Korean Adults With HypertensionCompletedNCT02203916Phase 3Results posted
• Azilsartan/Amlodipine Combination Tablets LD & HD Specified Drug-use Survey "Long-term Use Survey"CompletedNCT02181816Results posted
• Blopress Tablets Specified Drug-use Survey "Hypertension: Survey on Patients With Metabolic Syndrome"CompletedNCT02166697Results posted
• Azilsaltan Tablets (Azilva Tablets) Special Drug Use Surveillance "Hypertension Complicated by Diabetes "CompletedNCT02100319Results posted
• Azilsartan Tablets Special Drug Use Surveillance: Long-term UseCompletedNCT02092025Results posted
• A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-RCompletedNCT02079805Phase 4Results posted
• Candesartan Cilexetil/Amlodipine Besilate Combination Tablets LD, HD Special Drug Use Surveillance "Hypertension: Long-Term Use"CompletedNCT02068495Results posted
• Candesartan Cilexetil / Hydrochlorothiazide Combination Tablets Special Drug Use Surveillance: Long-term Use (12 Months)CompletedNCT02016183Results posted
• Effect of Febuxostat on Blood PressureCompletedNCT01496469Phase 2Results posted
• Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and DiabetesTerminatedNCT01496430Phase 3Results posted
• A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil AloneCompletedNCT01456169Phase 3Results posted
• A Comparative Single-Dose Pharmacokinetic (PK) and Safety Study of Azilsartan Medoxomil in Children With Hypertension and in Healthy AdultsTerminatedNCT01078376Phase 1Results posted
• Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.CompletedNCT01033071Phase 3Results posted
• Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential HypertensionCompletedNCT00996281Phase 3Results posted
• Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe HypertensionCompletedNCT00847626Phase 3Results posted
• Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe HypertensionCompletedNCT00846365Phase 3Results posted
• Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe HypertensionCompletedNCT00818883Phase 3Results posted
• Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential HypertensionCompletedNCT00760214Phase 3Results posted
• An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.CompletedNCT00696436Phase 3Results posted
• A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential HypertensionCompletedNCT00696384Phase 3Results posted
• Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential HypertensionCompletedNCT00696241Phase 3Results posted
• One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential HypertensionCompletedNCT00695955Phase 3Results posted
• Efficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential HypertensionCompletedNCT00591773Phase 3Results posted
• Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential HypertensionCompletedNCT00591578Phase 3Results posted
• Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential HypertensionCompletedNCT00591266Phase 3Results posted
• Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential HypertensionCompletedNCT00591253Phase 3Results posted
• Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate HypertensionCompletedNCT00362115Phase 2Results posted
• An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential HypertensionWithdrawnNCT02969265Phase 3
• Epidemiological Study in Thai Participants With HypertensionCompletedNCT02467855
• Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.CompletedNCT02072330Phase 2/3
• Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential HypertensionCompletedNCT01289132Phase 2
• Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe HypertensionCompletedNCT01012479Phase 4
• Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.CompletedNCT00775814Phase 4
• Efficacy Study of Pioglitazone and Ramipril Combination Therapy in Treating Non-diabetic Hypertensive Patients.CompletedNCT00770497Phase 2
• Efficacy and Safety of Azilsartan in Subjects With Essential HypertensionCompletedNCT00759551Phase 2